Skip to main content
Top
Published in: Supportive Care in Cancer 8/2013

01-08-2013 | Original Article

Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients

Authors: Shinichiro Morishita, Katsuji Kaida, Shinya Yamauchi, Koichiro Sota, Shinichi Ishii, Kazuhiro Ikegame, Norihiko Kodama, Hiroyasu Ogawa, Kazuhisa Domen

Published in: Supportive Care in Cancer | Issue 8/2013

Login to get access

Abstract

Purpose

The aim of this study was to investigate the relationship between corticosteroid dose and degree of physical function decrease in allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients during the early stage of recovery. We further investigated the confounding factors affecting loss of physical function.

Methods

The study included 113 patients who underwent allo-HSCT between July 2007 and April 2012 at Hyogo College of Medicine Hospital in Japan. Physical function was assessed using tests for hand-grip strength, knee-extensor strength, and the 6-min walk test (6MWT). Fatigue was measured using the Piper Fatigue Scale. Total corticosteroid dose, frequency of physical therapy, body weight, and nutritional status were also collected from medical records.

Results

Total corticosteroid dose was correlated with decrease of hand-grip and knee-extensors strength (P < 0.01) but was not correlated with 6MWT performance. Results of multivariate analysis confirmed that low physical function was associated not only with high corticosteroid dose but also with low frequency of physical therapy, increase in fatigue, and body weight loss (P < 0.05). Also, hemoglobin levels were associated with 6MWT (P < 0.05).

Conclusions

This study showed the relationship between corticosteroid dose and declines in physical function and also showed other clinical factors affecting loss of physical function among allo-HSCT patients. Our results indicate that the effectiveness of rehabilitation may be influenced by corticosteroid treatment.
Literature
1.
go back to reference Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu DP, Tong W, Ghavamzadeh A, Alimoghaddam K, Lie AK, Liang R, Chan LL, Haipeng L, Tan PL, Hwang WY, Chiou TJ, Chen PM, Van Binh T, Minh NN, Min CK, Hwang TJ, Kodera Y, Asia-Pacific Blood and Marrow Transplantation Group (APBMT) (2010) Hematopoietic SCT activity in Asia: a report from the Asia-Pacific blood and marrow transplantation group. Bone Marrow Transplant 45:1682–1691PubMedCrossRef Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu DP, Tong W, Ghavamzadeh A, Alimoghaddam K, Lie AK, Liang R, Chan LL, Haipeng L, Tan PL, Hwang WY, Chiou TJ, Chen PM, Van Binh T, Minh NN, Min CK, Hwang TJ, Kodera Y, Asia-Pacific Blood and Marrow Transplantation Group (APBMT) (2010) Hematopoietic SCT activity in Asia: a report from the Asia-Pacific blood and marrow transplantation group. Bone Marrow Transplant 45:1682–1691PubMedCrossRef
2.
go back to reference Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A, European group for blood and marrow transplantation (EBMT) (2012) The EBMT activity survey: 1990–2010. Bone Marrow Transplant 47:906–923PubMedCrossRef Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A, European group for blood and marrow transplantation (EBMT) (2012) The EBMT activity survey: 1990–2010. Bone Marrow Transplant 47:906–923PubMedCrossRef
4.
go back to reference Grulke N, Albani C, Bailer H (2012) Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire QLQ-C30. Bone Marrow Transplant 47:473–482PubMedCrossRef Grulke N, Albani C, Bailer H (2012) Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire QLQ-C30. Bone Marrow Transplant 47:473–482PubMedCrossRef
5.
go back to reference Tabbara IA, Zimmerman K, Morgan C, Nahleh Z (2002) Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 162:1558–1566PubMedCrossRef Tabbara IA, Zimmerman K, Morgan C, Nahleh Z (2002) Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 162:1558–1566PubMedCrossRef
6.
go back to reference Gillis T, Donovan E (2001) Rehabilitation following bone marrow transplantation. Cancer 92:998–1007PubMedCrossRef Gillis T, Donovan E (2001) Rehabilitation following bone marrow transplantation. Cancer 92:998–1007PubMedCrossRef
7.
go back to reference Gerber LH, Molnar A (2009) Graft-versus-host disease. In: Stubblefield MD, O’Dell MW (eds) Cancer rehabilitation principles and practice. Demos Medical, New York, pp 747–782 Gerber LH, Molnar A (2009) Graft-versus-host disease. In: Stubblefield MD, O’Dell MW (eds) Cancer rehabilitation principles and practice. Demos Medical, New York, pp 747–782
8.
go back to reference Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC (2008) Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant 41:965–969PubMedCrossRef Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC (2008) Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant 41:965–969PubMedCrossRef
9.
go back to reference Hacker ED, Larson J, Kujath A, Peace D, Rondelli D, Gaston L (2011) Strength training following hematopoietic stem cell transplantation. Cancer Nurs 34:238–249PubMedCrossRef Hacker ED, Larson J, Kujath A, Peace D, Rondelli D, Gaston L (2011) Strength training following hematopoietic stem cell transplantation. Cancer Nurs 34:238–249PubMedCrossRef
10.
go back to reference Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, Dieterle N (2006) Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 33:614–624PubMedCrossRef Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, Dieterle N (2006) Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 33:614–624PubMedCrossRef
11.
go back to reference Morishita S, Kaida K, Setogawa K, Kajihara K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. Eur J Cancer Care (Engl). doi:10.1111/ecc.12027 Morishita S, Kaida K, Setogawa K, Kajihara K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. Eur J Cancer Care (Engl). doi:10.​1111/​ecc.​12027
12.
go back to reference Baumann FT, Zopf EM, Nykamp E, Kraut L, Schüle K, Elter T, Fauser AA, Bloch W (2011) Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 87:148–156PubMedCrossRef Baumann FT, Zopf EM, Nykamp E, Kraut L, Schüle K, Elter T, Fauser AA, Bloch W (2011) Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 87:148–156PubMedCrossRef
13.
go back to reference Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psychooncology. doi:10.1002/pon.3128 Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psychooncology. doi:10.​1002/​pon.​3128
14.
go back to reference Salmasian H, Rohanizadegan M, Banihosseini S, Rahimi Darabad R, Rabbani-Anari M, Shakiba A, Ferrara JL (2010) Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Database Syst Rev 1:CD005565PubMed Salmasian H, Rohanizadegan M, Banihosseini S, Rahimi Darabad R, Rabbani-Anari M, Shakiba A, Ferrara JL (2010) Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Database Syst Rev 1:CD005565PubMed
15.
go back to reference Menconi M, Fareed M, O’Neal P, Poylin V, Wei W, Hasselgren PO (2007) Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35:S602–S608PubMedCrossRef Menconi M, Fareed M, O’Neal P, Poylin V, Wei W, Hasselgren PO (2007) Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35:S602–S608PubMedCrossRef
16.
go back to reference Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A, Ozaki S, Nakao K (2006) High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int 17:105–108PubMedCrossRef Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A, Ozaki S, Nakao K (2006) High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int 17:105–108PubMedCrossRef
17.
go back to reference Fardet L, Flahault A, Kettaneh A, Tiev KP, Généreau T, Tolédano C, Lebbé C, Cabane J (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol 157:142–148PubMedCrossRef Fardet L, Flahault A, Kettaneh A, Tiev KP, Généreau T, Tolédano C, Lebbé C, Cabane J (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol 157:142–148PubMedCrossRef
18.
go back to reference Nava S, Fracchia C, Callegari G, Ambrosino N, Barbarito N, Felicetti G (2002) Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 20:497–499PubMedCrossRef Nava S, Fracchia C, Callegari G, Ambrosino N, Barbarito N, Felicetti G (2002) Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 20:497–499PubMedCrossRef
19.
go back to reference Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML (2005) High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 43:199–203PubMedCrossRef Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML (2005) High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 43:199–203PubMedCrossRef
20.
go back to reference Hopkinson NS, Man WD, Dayer MJ, Ross ET, Nickol AH, Hart N, Moxham J, Polkey MI (2004) Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 24:137–142PubMedCrossRef Hopkinson NS, Man WD, Dayer MJ, Ross ET, Nickol AH, Hart N, Moxham J, Polkey MI (2004) Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 24:137–142PubMedCrossRef
21.
go back to reference Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P, Neumann J, de Lima M, Champlin R, Giralt S (2006) Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 38:299–303PubMedCrossRef Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P, Neumann J, de Lima M, Champlin R, Giralt S (2006) Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 38:299–303PubMedCrossRef
22.
go back to reference Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H (2008) Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biol Blood Marrow Transplant 14:896–903PubMedCrossRef Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H (2008) Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biol Blood Marrow Transplant 14:896–903PubMedCrossRef
23.
go back to reference Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I (2006) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 12:1073–1084PubMedCrossRef Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I (2006) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 12:1073–1084PubMedCrossRef
24.
go back to reference Ogawa H, Ikegame K, Kaida K, Yoshihara S, Fujioka T, Taniguchi Y, Tamaki H, Inoue T, Hasei H, Iiboshi Y, Tazuke Y, Kawakami M, Kim EH, Soma T, Inoue T, Kawase I (2008) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 36:1–8PubMedCrossRef Ogawa H, Ikegame K, Kaida K, Yoshihara S, Fujioka T, Taniguchi Y, Tamaki H, Inoue T, Hasei H, Iiboshi Y, Tazuke Y, Kawakami M, Kim EH, Soma T, Inoue T, Kawase I (2008) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 36:1–8PubMedCrossRef
25.
go back to reference Katoh M, Yamasaki H (2009) Comparison of reliability of isometric leg muscle strength measurements made using a hand-held dynamometer with and without a restraining belt. J Phys Ther Sci 21:37–42CrossRef Katoh M, Yamasaki H (2009) Comparison of reliability of isometric leg muscle strength measurements made using a hand-held dynamometer with and without a restraining belt. J Phys Ther Sci 21:37–42CrossRef
26.
go back to reference Katoh M, Yamasaki H (2009) Test-retest reliability of isometric leg muscle strength measurements made using a hand-held dynamometer restrained by a belt: comparisons during and between sessions. J Phys Ther Sci 21:239–243CrossRef Katoh M, Yamasaki H (2009) Test-retest reliability of isometric leg muscle strength measurements made using a hand-held dynamometer restrained by a belt: comparisons during and between sessions. J Phys Ther Sci 21:239–243CrossRef
27.
go back to reference ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef
28.
go back to reference Sciurba F, Criner G, Lee S, Mohsenifar Z, Shade D, Slivka W, Wise RA, National Emphysema Treatment Trial Research Group (2003) Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 167:1522–1527PubMedCrossRef Sciurba F, Criner G, Lee S, Mohsenifar Z, Shade D, Slivka W, Wise RA, National Emphysema Treatment Trial Research Group (2003) Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 167:1522–1527PubMedCrossRef
29.
go back to reference Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed
30.
go back to reference Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM (1997) Steroid myopathy in cancer patients. Neurology 48:1234–1238PubMedCrossRef Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM (1997) Steroid myopathy in cancer patients. Neurology 48:1234–1238PubMedCrossRef
31.
go back to reference Barry SC, Gallagher CG (2003) Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 95:1379–1384PubMed Barry SC, Gallagher CG (2003) Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 95:1379–1384PubMed
32.
go back to reference Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, D’Antona G (2011) Steroid myopathy: some unresolved issues. J Endocrinol Invest 34:370–375PubMed Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, D’Antona G (2011) Steroid myopathy: some unresolved issues. J Endocrinol Invest 34:370–375PubMed
33.
go back to reference Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, Ulrich CM, Bohus M (2011) Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 117:2604–2613PubMedCrossRef Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, Ulrich CM, Bohus M (2011) Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 117:2604–2613PubMedCrossRef
34.
go back to reference Jarden M, Baadsgaard M, Hovgaard D, Boesen E, Adamsen L (2009) A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 43:725–737PubMedCrossRef Jarden M, Baadsgaard M, Hovgaard D, Boesen E, Adamsen L (2009) A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 43:725–737PubMedCrossRef
35.
go back to reference Baumann FT, Kraut L, Schüle K, Bloch W, Fauser AA (2010) A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 45:355–362PubMedCrossRef Baumann FT, Kraut L, Schüle K, Bloch W, Fauser AA (2010) A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 45:355–362PubMedCrossRef
36.
go back to reference Angst F, Drerup S, Werle S, Herren DB, Simmen BR, Goldhahn J (2010) Prediction of grip and key pinch strength in 978 healthy subjects. BMC Musculoskelet Disord 11:94PubMedCrossRef Angst F, Drerup S, Werle S, Herren DB, Simmen BR, Goldhahn J (2010) Prediction of grip and key pinch strength in 978 healthy subjects. BMC Musculoskelet Disord 11:94PubMedCrossRef
37.
go back to reference Bohannon RW (1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 78:26–32PubMedCrossRef Bohannon RW (1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 78:26–32PubMedCrossRef
38.
go back to reference Poh H, Eastwood PR, Cecins NM, Ho KT, Jenkins SC (2006) Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology 11:211–216PubMedCrossRef Poh H, Eastwood PR, Cecins NM, Ho KT, Jenkins SC (2006) Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology 11:211–216PubMedCrossRef
39.
go back to reference Morishita S, Kaida K, Ikegame K, Yoshihara S, Taniguchi K, Okada M, Kodama N, Ogawa H, Domen K (2012) Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. Support Care Cancer 20:821–829PubMedCrossRef Morishita S, Kaida K, Ikegame K, Yoshihara S, Taniguchi K, Okada M, Kodama N, Ogawa H, Domen K (2012) Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. Support Care Cancer 20:821–829PubMedCrossRef
40.
go back to reference Bevans M, Wehrlen L, Prachenko O, Soeken K, Zabora J, Wallen GR (2011) Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. Psychooncology 20:615–622PubMedCrossRef Bevans M, Wehrlen L, Prachenko O, Soeken K, Zabora J, Wallen GR (2011) Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. Psychooncology 20:615–622PubMedCrossRef
41.
go back to reference Morishita S, Kaida K, Tanaka T, Itani Y, Ikegame K, Okada M, Ishii S, Kodama N, Ogawa H, Domen K (2012) Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer 20:3161–3168PubMedCrossRef Morishita S, Kaida K, Tanaka T, Itani Y, Ikegame K, Okada M, Ishii S, Kodama N, Ogawa H, Domen K (2012) Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer 20:3161–3168PubMedCrossRef
42.
go back to reference Calbet J, Lundby C, Koskolou M, Boushel R (2006) Importance of hemoglobin concentration to exercise: acute manipulations. Respir Physiol Neurobiol 151:132–140PubMedCrossRef Calbet J, Lundby C, Koskolou M, Boushel R (2006) Importance of hemoglobin concentration to exercise: acute manipulations. Respir Physiol Neurobiol 151:132–140PubMedCrossRef
43.
go back to reference Bellotto F, Palmisano P, Compostella L, Russo N, Zaccaria M, Guida P, Setzu T, Cati A, Maddalozzo A, Favale S, Iliceto S (2011) Anemia does not preclude increments in cardiac performance during a short period of intensive, exercise-based cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil 18:150–157PubMedCrossRef Bellotto F, Palmisano P, Compostella L, Russo N, Zaccaria M, Guida P, Setzu T, Cati A, Maddalozzo A, Favale S, Iliceto S (2011) Anemia does not preclude increments in cardiac performance during a short period of intensive, exercise-based cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil 18:150–157PubMedCrossRef
44.
go back to reference Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA (2007) Six minute walk test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 13:3996–4001PubMed Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA (2007) Six minute walk test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 13:3996–4001PubMed
Metadata
Title
Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients
Authors
Shinichiro Morishita
Katsuji Kaida
Shinya Yamauchi
Koichiro Sota
Shinichi Ishii
Kazuhiro Ikegame
Norihiko Kodama
Hiroyasu Ogawa
Kazuhisa Domen
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1778-7

Other articles of this Issue 8/2013

Supportive Care in Cancer 8/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine